iShares Russell 1000

After closing above its May 10 IPO listing price of $45 for the first time yesterday, Uber (UBER) was up 4% today. Can the rally last?

George Soros added 2.026 million shares of the SPDR Select Sector Fund (XLF) to its portfolio during the fourth quarter, giving it a weight of 1.5% in the portfolio.

Tesla (TSLA) has been one of the handful of positive-return-yielding stocks in the fourth quarter so far.

Musk seems to have found ways to retain power while meeting the SEC’s obligatory measures at the same time. Let’s take a closer look.

Wedbush Securities analyst Dan Ives expects Tesla Model 3 demand to remain “very strong into 2019 and beyond.”

Tesla has lost about 9.8% month-to-date as of December 27.

December is proving to be underwhelming for Tesla investors (IWB).

Before Tesla, many automakers launched limited-production electric models only to discontinue them soon after.

On December 26, 2017, 78% of the Wall Street analysts tracking Weatherford International rated it a “buy” or some equivalent.

National Oilwell Varco’s (NOV) management has identified demand growth in hydraulic fracturing equipment, closed-loop drilling, downhole tools, and completion tools.

In this article, we’ll look Wall Street’s call and target price for Weatherford International (WFT) on September 12.

Does National Oilwell management see a recovery in 2017? National Oilwell Varco (NOV) management identified strong US onshore activity and weak offshore energy exploration and production activity as the drivers behind its changing revenue mix in 2Q17. In the company’s 2Q17 conference call, chairman and CEO Clay C. Williams stated that “much of our business […]

Baker Hughes’s (BHGE) CFO (cash from operating activities) remained negative in 2Q17, continuing its negative cash flow trend in 1Q17.

Baker Hughes’s (BHGE) North America segment saw 16.5% higher revenues from 2Q16 to 2Q17.

National Oilwell Varco’s (NOV) management expressed concern over upstream energy companies’ lower capex spending, which is negative for the oilfield services companies.

In this article, we’ll look Wall Street analysts’ recommendations for Weatherford International (WFT) as of June 7, 2017.

Schlumberger’s (SLB) net debt rose 65% in 1Q17—compared to 1Q16. Its net debt was ~$11.7 billion in 1Q17.

Medtronic (MDT) reported ~$7.9 billion in worldwide revenues in fiscal 4Q17.

On May 9, 2017, Boston Scientific (BSX) announced the FDA approval of its Resonate family of products, including its ICD and CRT-D systems.

National Oilwell Varco’s (NOV) net debt increased 4% in 1Q17 over 1Q16. Its net debt amounted to ~$1.7 billion in 1Q17.

Let’s take a look at some of the projects that could affect National Oilwell Varco’s (NOV) returns going forward.

National Oilwell Varco’s (NOV) total debt decreased ~18% in 4Q16 over 4Q15. Its cash and marketable securities decreased 31% during the same period.

National Oilwell Varco’s (NOV) management expects upstream activity in North America’s shale plays to improve in 2017.

On March 1, ~71% of the analysts tracking Weatherford International rated it as a “buy,” ~20% rated it as a “hold,” and the rest rated it as a “sell.”

For fiscal 1Q17, AMAT expects its non-GAAP (generally accepted accounting principles) gross margin to rise 43.8% from 43.7% in fiscal 4Q16.

Unlike Biogen (BIIB) and Eli Lilly, who have focused their attention on amyloid-beta based therapeutics, AbbVie (ABBV) is reluctant to enter this field.

AbbVie (ABBV) plans to complete its Phase 3 registrational program for investigational next-generation Hepatitis C virus (or HCV) therapy by 2016.

Of Medtronic’s ~$7.3 billion in worldwide revenues in fiscal 2Q17, ~$2.6 billion came from Medtronic’s CVG segment, representing ~35% of the company total.

Together, AbbVie (ABBV) and Neurocrine Biosciences (NBIX) aim to develop Elagolix as a minimally invasive yet effective therapy for uterine fibroids

On June 24, 2016, Pfizer (PFE) announced that it had completed the acquisition of Anacor Pharmaceuticals for a total net value of $5.2 billion. The acquisition added crisaborole.

National Oilwell Varco’s (NOV) net debt (total debt less cash & marketable securities) fell 20% in 3Q15.

On September 30, 2016, National Oilwell Varco’s (NOV) share price was 10% higher compared to December 31, 2015.

National Oilwell Varco’s (NOV) management expects most of the upstream recovery in North America to take place in 2H17.

Since January 2015, Amgen has traded at a premium to Gilead Sciences (GILD) but at a significant discount to peers Biogen (BIIB) and Celgene (CELG).

After the release of the FOMC’s November statement, Bill Gross said that monetary policy in the United States is steadily moving toward normalization, though its pace is slow.

In the first nine months of 2016, Amgen witnessed strong volume growth for its key products such as Xgeva, Prolia, Nplate, Vectibix, and Sensipar.

Medivation has added its robust research pipeline with two promising investigational drugs, Talazoparib and Pidilizumab, to Pfizer’s oncology portfolio.

On September 20, 2016, Medtronic posted its new safety and efficacy data for its Valiant Captivia Thoracic Stent Graft System.

Boston Scientific (BSX) is consistently working towards gaining higher market share in the attractive TAVR (transcatheter aortic valve replacement) market in Europe.

Bristol-Myers Squibb’s and AbbVie’s multiple myeloma drug Empliciti, combined with Celgene’s Revlimid and dexamethasone, received approval from the FDA.

As of August 26, 2016, PPG Industries was trading at a one-year forward PE multiple of 16.0x compared to Sherwin-Williams and Valspar at 21.20x and 20.30x, respectively.

According to Richard Bernstein, the five charts in the recent edition of his newsletter are “five of our favorite charts that highlight what we think consensus is currently missing.”

AbbVie (ABBV) expects to file a biologics license application for Rova-T as a third-line therapy for small cell lung cancer (or SCLC) in 2017.

TJX Companies anticipates its TJX Canada segment to deliver same-store sales growth of 7%–8% in fiscal 2017 and sales of $3.1 billion–$3.2 billion.

In 2Q16, LyondellBasell’s (LYB) Olefins & Polyolefins – Europe, Asia, and International (or EAI) segment reported revenue of $2.7 billion.

Gilead Sciences reported diluted earnings per share (or EPS) of about $3.08 in 2Q16, which is a year-over-year (or YoY) decline of 2.2%.

We could see fewer jobs added going forward. If this trend continues, bond (AGG) (BND) yields could most likely stay low.

Biogen’s investigational Alzheimer’s disease drug, aducanumab, is one of the four therapies accepted in the EMA’s Priority Medicines program (or PRIME).

A QE program doesn’t just create inflation; it causes asset prices to rise as well. After the financial crisis of 2008, the Fed resorted to an ultra-accommodative monetary policy.

As of July 22, 2016, Air Products and Chemicals (APD) was trading at a one-year forward PE multiple of 18.8x compared to its peers Praxair and FMC.

Johnson & Johnson (JNJ) registered sales of approximately $6.4 billion in its Medical Devices business in 2Q16.

Estée Lauder (EL) ended calendar 1Q16 with a 3.5% rise in inventory.

A robust pipeline and strong R&D (research and development) capabilities are expected to drive significant revenue growth for JNJ’s Medical Devices segment.

Alnylam Pharmaceuticals (ALNY) is currently developing three investigational therapies—Patisiran, Revusiran, and ALN-TTRsc02—for the treatment of patients with hereditary ATTR amyloidosis.

Amazon (AMZN), in order to keep its Prime membership popular, is offering two unlocked Android smartphones exclusively priced for Prime members.

As part of its restructuring initiative, Micron would only focus on critical projects and cut 2,400 jobs.

In fiscal 1Q17, which ended on May 31, 2016, Constellation Brands’ gross margin increased significantly to 47.1% from 45.2% in fiscal 1Q16.

The global eSports market is expected to reach $1 billion in 2017. Approximately one-third of the eSports fans in the United States participate in online amateur tournaments.

Take-Two Interactive Software’s (TTWO) most successful franchise, Grand Theft Auto (or GTA), has sold over 235 million units worldwide.

Medtronic’s (MDT) Restorative Therapies Group (or RTG) segment, formed around seven years ago, has a strong market position today.

Recently, Qualcomm launched an LTE (long-term evolution) modems for battery-powered IoT devices to increase their communication range.

When asked about a bear market, Gundlach took the opportunity to present some numbers. Currently, he’s in capital preservation mode.

Now in its phase-1 clinical trial, AbbVie’s PF-06647020, an ADC targeting protein kinase 7 could become a major therapy for advanced solid tumors.

During Cypress’s fiscal 1Q16 earnings call, CEO Thurman John Rodgers explained that Broadcom offloaded the wireless IoT segment for two reasons.

IoT has a huge potential to create value for technology firms in the form of hardware, software, services, and integration.

Analog Devices (ADI) has been using M&A (mergers and acquisitions) to rapidly expand its technology offerings and boost its revenue.

A key semicond trend is likely to intensify as the automotive market progresses toward self-driving cars.

The company’s debt burden rose after it raised new debt to fund its $12 billion acquisition of Freescale. It also took on Freescale’s debt burden.

As Xilinx increases its share in the PLD market, a key will be its success in the long term is its competitive positioning compared to rival Altera.

Texas Instruments (TXN) has increased its exposure in the automotive, industrial, and communications segments, which accounted for 64% of the company’s revenue in fiscal 1Q16.

Richard Bernstein spoke with CNBC’s Michael Santoli about what drives stock markets. He noted that his firm employs a top-down, macro research approach.

Boston Scientific’s (BSX) MedSurg segment contributes around 33% to the company’s total revenues and is the company’s second-largest segment.

Celgene has been working on its immunomodulatory backbone drugs to develop combination therapies for use in treating all lines of multiple myeloma.

With same-store sales growth being lowered, it is expected that Papa John’s (PZZA) EPS will also be revised downward.

In fiscal 1Q16, SanDisk’s (SNDK) revenue rose 3% YoY, topping analysts’ estimate and its own guidance. This was the first growth after four consecutive quarters of decline.

On April 28, 2016, AbbVie (ABBV) announced its plans to acquire Stemcentrx. The deal is expected to be completed at a consideration of about $5.8 billion.

For fiscal 3Q16, Qualcomm’s (QCOM) expects MSM shipments to be between 175 million–195 million units, the same guidance as reported for fiscal 2Q16.

In fiscal 1Q16, Intel’s non-GAAP revenues rose by 8% YoY to $13.8 billion, missing the analyst estimate of $13.83 billion, which was a conservative one.

Although Intel (INTC) reported revenue growth across all major business segments, it missed the analyst revenue estimate by $30 million.

UnitedHealth Group’s healthcare delivery business, OptumHealth, managed to earn $4 billion revenues in 1Q16, which represents a YoY growth of about 22%.

In this part of the series, we’ll look at what Wall Street analysts recommend for Kinder Morgan (KMI).

Kinder Morgan (KMI) announced a reduction in 2016 EBITDA and distributable cash flow guidance by 3% and 4%, respectively.

With Zen, AMD looks poised to regain some share in the server and PC processor market. The question that remains is twofold: how much, and for how long?

According to a Root Metrics report, Sprint’s position in the network reliability parameter improved two notches from its score in 2H15.

Micron and Intel have developed 3D XPoint in a way that benefits from both DRAM (dynamic random access memory) and NAND (negative AND).

Coffee lovers in the United States are boosting ready-to-drink coffee volumes.

Generally recognized as the world’s best-selling international cigarette, Marlboro accounted for 33.7% of the company’s total shipment volume in 2015.

Amgen expects Neupogen to lose market share in 2016. In 2015, Neupogen lost 3% market share in the United States due to biosimilar competition and branded competition.

The pace of recent job and wage growth indicates that the labor market remained weak despite a decline in the unemployment rate. The labor force participation rate has not increased substantially in recent years with the improvement in the economy.

Celgene (CELG) expects Otezla to attain blockbuster therapy status by earning about $1 billion in revenues for 2016. In 2015, the drug managed to earn revenues of about $471.7 million.

As of March 11, 2016, AT&T was the largest global telecommunication player by market capitalization.

Still beverage volumes gained strength in 4Q15 as consumers continued to shift from sugary soda beverages to healthier options.

Buffett said that it has been a terrible mistake to bet against America, not only for the past 240 years but even now. He believes that America’s emphasis on innovation and strength in commerce will continue to provide strong gains for its people.

With this partnership, approximately 80% of companies that run VMware’s vSphere can be shifted to IBM’s cloud.

AbbVie (ABBV) has been actively expanding Humira’s label and expects to earn annual revenues worth $18 billion from the sales of the drug in 2020.

Atmel has a PE (price-to-equity) ratio of 80.3, which is way higher than Intel’s (INTC) 12.9, Texas Instrument’s (TXN) 18.19, and Microchip’s (MCHP) 26.9.

JCPenney’s earnings were ahead of the consensus Wall Street analysts’ estimate of $0.21 per share.

In a 4Q15 conference call on February 25, Monster Beverage’s (MNST) chair and chief executive officer, Rodney Cyril Sacks, discussed a proposed acquisition of the California-based American Fruits & Flavors.

Best Buy (BBY) expects its revenue to keep falling in the first half of fiscal 2017, which ends on January 28, 2017, based on the current industry dynamics.

RAI’s increase in revenue was driven by the continued strong performance of Vuse Digital Vapor Cigarette in 4Q15.